Ikram Guerd

AI meets Rheumatology: ChatGPT and patient response optimization Large language models like ChatGPT, trained on vast text data, are revolutionizing healthcare by understanding and generating human-like language.

1

[Transform your engagement with HCPs] - Combining video and email is the ultimate powerhouse for engaging physicians and motivating them to take action! 🎥📧 This dynamic duo creates an unbeatable strategy you can't afford to miss. Imagine sending a captivating video directly to their inbox – it’s the perfect way to grab attention and inspire action. Ready to transform your pharma email campaigns and see incredible results? 🚀 www.viihealth.com #viihealth #digitalengagement #personalizedvideo #AI #pharma #healthcaremarketing

6

Elevate your diabetes care with the Innovations and Latest Treatments in Type 1 Diabetes program. Learn to implement latest guidelines, address barriers, and harness diabetes tech. Explore key topics like screening, genetics, disease management, and emerging therapies. Start learning today! https://bit.ly/46TxHJG

41

5 Comments

📢 Communication is KEY in medical affairs – here’s what we learned from #medicalaffairs leaders in collaboration with Medical Affairs Professional Society (MAPS) 👇

4

👀 Changes in the retinal microvasculature could be the key to early detection of cardiovascular issues. Optical coherence tomography angiography, as discussed in our review by Dr. Emily Patterson and colleagues including Dr. Siegfried Wagner, shows promising potential as a non-invasive screening tool. 🔗 Discover the research in "Oculomics: A Crusade Against the Four Horsemen of Chronic Disease": Read the full article #CardiovascularHealth #Ophthalmology #InnovativeDiagnostics

1

As #AlzheimersAwarenessMonth comes to a close, we’re reflecting on our partnership with the Alzheimer's Association®. This collaboration culminated in the Alzheimer’s Association Pitch Competition, which fosters innovation in Alzheimer’s care. The following startups were selected as the winners of the 2023 and 2024 competitions, respectively: 🧠 Neurotrack, a clinically-validated digital cognitive assessment that measures and monitors the state of one’s cognition paired with its cognitive health program that enables individuals to make lifestyle changes to strengthen their cognitive health as they age. 🚙 Onward, a door-through-door companion rideshare services and transportation management solution. Onward works to eradicate transportation as a barrier to timely healthcare and reduce caregiver burden.  Learn more about how MATTER supports corporate innovation ➡️ https://bit.ly/4aSovqd

16

Did you know that asthma affects 27 million people alone in the U.S.? Asthma, a long-term disease, makes breathing difficult for people. With proper treatment, it is possible to control your asthma. Share this video to spread more awareness. #WorldAsthmaDay #asthmaawareness #AsthmaAwarenessMonth #AsthmaPrevention #newjerseyhospital #AdvancedMedicalGroup #AsthmaDay

1

Thoughts on this? >> Olive Union Olive Max Hearing Aids: For Mild Hearing Loss >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #industry40 #IoT #AI #mhealth #healthtech

1

🌬️Did you know that one in 13 people live with #asthma in the United States? That’s over 25 million people. Let's spread awareness this Asthma Awareness Month to ensure everyone knows how to manage and support those living with asthma. Learn all things #asthma - https://lnkd.in/e2MkrWWc #AAAM #AsthmaAndAllergyAwarenessMonth

23

1 Comment

Deeper Data. Better Outcomes. Focusing on long-term care can significantly benefit underrepresented patients and vulnerable populations by improving access to therapies and coordinating care, leading to better outcomes. Learn more: https://lnkd.in/eRuphcNT #LongTermCare #Biopharmaceuticalnnovation #SilverSurge #LifeSciences

14

All of our workshop topics are recapped by a special She Should Know podcast . Did you catch the latest She Should Know episode? 🎙️ Dive into the discussion on Ozempic with both a health + fiqh perspective from Dr. Sarah Hemeida and Alimah Sarah Ahmed out now! #SheShouldKnow #Ozempic #EmpowHer #PodcastDrop

1

𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗪𝗲𝗯𝘀𝗶𝘁𝗲𝘀 Seeing a recent surge in small and midsized pharma companies creating (or improving) medical affairs websites, and here's why: 🔹 𝘿𝙖𝙩𝙖 𝙎𝙝𝙖𝙧𝙞𝙣𝙜: Companies reach a point where they have enough data to justify a dedicated site. 🔹 𝙏𝙧𝙪𝙨𝙩 𝘽𝙪𝙞𝙡𝙙𝙞𝙣𝙜: These sites enhance credibility and transparency. 🔹 𝘾𝙤𝙢𝙥𝙡𝙞𝙖𝙣𝙘𝙚: Easier to meet regulatory requirements. 🔹 𝙀𝙣𝙜𝙖𝙜𝙚𝙢𝙚𝙣𝙩: Improved access to info for HCPs, regulators, and even patients. 🔍 𝙋𝙖𝙩𝙞𝙚𝙣𝙩 𝘾𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙤𝙣𝙨 𝙖𝙣𝙙 𝙁𝘿𝘼 𝙎𝙄𝙐𝙐 𝘿𝙧𝙖𝙛𝙩 𝙂𝙪𝙞𝙙𝙖𝙣𝙘𝙚: Traditionally focused on HCPs, there's now a growing call for direct-to-patient communications. The Medical Affairs Professional Society recently discussed the opportunities and risks of ensuring patients have direct access to clear, unbiased information. Additionally, new FDA draft guidance may allow discussions on unapproved uses of approved products, providing HCPs with more tools for patient care. Check out my article on best practices for med affairs sites. #pharma #pharmaceutical #medicalaffairs #marketing #biopharma #communications #clinicaltrials

6

Key takeaways from Reuters Pharma 2024: 🔵 1/3+ of Europe’s population suffers from chronic diseases, underscoring the urgent need for proactive digital healthcare solutions. 🔵 50%+ of the population feels neglected by the current healthcare system, emphasizing the importance of patient-centricity and access to healthcare. 🔵 Biotech emerges as the driving force behind Europe’s economy, signaling a strong demand for innovation to maintain competitiveness. Innovation in healthcare is not merely desirable, but rather a moral imperative 🤔 #REPharma2024

41

WHO prequalifies the first self-test for hepatitis C virus The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C. The product, called OraQuick HCV self-test, manufactured by OraSure Technologies, is an extension of the pre-qualified, OraQuick® HCV Rapid Antibody Test which was initially prequalified by WHO in 2017 for professional use. The self-test version, specifically designed for use by lay users, provides individuals with a single kit containing the components that are needed to perform the self-test. WHO recommended HCV self-testing (HCVST) in 2021, to complement existing HCV testing services in countries. The recommendation was based on evidence demonstrating its ability to increase access to and uptake of services, particularly among people who may not otherwise test. National-level HCVST implementation projects, largely supported by Unitaid, have shown high levels of acceptability and feasibility, as well as empowering people through personal choice, autonomy and access to stigma-free self-care services. “Every day 3500 lives are lost to viral hepatitis. Of the 50 million people living with hepatitis C, only 36% had been diagnosed, and 20% have received curative treatment by the end of 2022,” says Dr Meg Doherty, WHO Director for the Department of Global HIV, Hepatitis and STI Programmes. “The addition of this product to the WHO prequalification list provides a safe and effective way to expand HCV testing and treatment services, ensuring more people receive the diagnoses and treatment they need, and ultimately contributing to the global goal of HCV elimination.” WHO’s prequalification (PQ) programme for in vitro diagnostics (IVDs) evaluates a range of tests, including those used for the detection of antibodies to HCV. The programme assesses IVDs against quality, safety and performance standards. It is a cornerstone in supporting countries in achieving high-quality diagnosis and treatment monitoring. “The availability of a WHO prequalified HCV self-test enables low- and middle-income countries have access to safe and affordable self-testing options which is essential to achieving the goal of 90% of all people with HCV to be diagnosed,” says Dr Rogério Gaspar, WHO Director for the Department of Regulation and Prequalification. “This achievement contributes to improving access to quality-assured health products for more people living in low-income countries.” WHO will continue to assess additional HCV self-tests, support evidence-based implementation, and work with communities to expand available options to all countries.

11

1 Comment

Honoring World Asthma Day! Today, we unite to raise awareness about asthma, a chronic respiratory condition affecting millions worldwide. Let's come together to empower individuals with asthma to lead fulfilling lives. Asthma impacts over 339 million people globally, with numbers steadily rising. This year's theme, "Asthma Education Empowers", highlighting the significance of unity and cooperation in tackling the obstacles encountered by individuals with asthma on a global scale. Let's equip ourselves with knowledge, support, and resources to break barriers and ensure everyone with asthma can thrive. As professionals, let's strive for inclusive workplaces and accommodations, fostering environments where individuals with asthma can excel. Join the conversation! Share your experiences, insights, and support using #WorldAsthmaDay. Together, we can breathe easier and build a healthier future for all. #AsthmaAwareness #Healthcare #Wellness #Community #GlobalHealth #WorldAsthmaDay2024 #Mascot #Pharmaceutical #manufacturing

16

We are #HereForYou to help navigate a challenging healthcare journey. We invite you to read our newest #Blog post which highlights the commonality of Chronic Kidney Disease, and unmasking this silent epidemic with a breakdown of facts, statistics, relevance to differing demographics. Click here to learn more about #CKD: https://lnkd.in/e8ZsZRGg

8